Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Republic HealthcareHKSE:08357 30 PB Ratio is 1.32 as of Aug. 24, 2026, which is 16% below its 10-year median of 1.58. GuruFocus rates HKSE:08357 with a GF Score™ of 30/100 and a GF Value™ of HK$0.09 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Republic Healthcare ranks better than 70.05% on this metric.
The historical rank and industry rank for Republic Healthcare's PB Ratio or its related term are showing as below:
HKSE:08357'
s PB Ratio Range Over the Past 10 Years
Min: 0.47 Med: 1.58 Max: 41.58
Current: 1.29
During the past 10 years, Republic Healthcare's highest PB Ratio was 41.58. The lowest was 0.47. And the median was 1.58.
HKSE:08357's PB Ratio is ranked better than 70.05% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.97
vs HKSE:08357: 1.29
During the past 12 months, Republic Healthcare's average Book Value Per Share Growth Rate was -29.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -10.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -7.90% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Republic Healthcare was 97.30% per year. The lowest was -10.00% per year. And the median was -4.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Republic Healthcare PB Ratio Related Terms
Republic Healthcare PB Ratio Historical Data
* Premium members only.
The historical data trend for Republic Healthcare's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Republic Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Republic Healthcare PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Republic Healthcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Republic Healthcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Republic Healthcare (HKSE:08357) has a PB Ratio of 1.32 as of Aug. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Republic Healthcare and its competitors. This is 16% below median its historical median of 1.58. Over the past decade, Republic Healthcare's PB Ratio has ranged from 0.47 to 41.58. According to the industry distribution chart, Republic Healthcare ranks #183 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 30%.
Is Republic Healthcare's PB Ratio too high?
Republic Healthcare's current PB Ratio of 1.32 is 16% below median its 10-year median of 1.58. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 41.58. The Healthcare Providers & Services industry median PB Ratio is 1.97. Republic Healthcare's value of 1.32 is 33% below this industry median. Based on the distribution chart, Republic Healthcare ranks #183 out of 611 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Republic Healthcare has a GF Score™ of 30/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Republic Healthcare's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Republic Healthcare ranks #183 out of 611 companies for PB Ratio. This puts Republic Healthcare in the upper half of its industry. The industry median PB Ratio is 1.97. Republic Healthcare's value of 1.32 is 33% below this benchmark. Historically, Republic Healthcare's own PB Ratio has ranged from 0.47 to 41.58 over the past decade. While the company's 10-year median is 1.58 vs. the industry median of 1.97, Republic Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.97, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Republic Healthcare's current PB Ratio of 1.32 is 33% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Republic Healthcare and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Republic Healthcare's current PB Ratio is 1.32, which is 16% below median its own 10-year median of 1.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Republic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Republic Healthcare (HKSE:08357) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.09, compared to a current price of HK$0.10 — trading 14.4% above its estimated fair value. The current PB Ratio is 1.32, which is 16% below median its 10-year median of 1.58 and 33% below the Healthcare Providers & Services industry median of 1.97. Republic Healthcare's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Republic Healthcare (HKSE:08357), the current PB Ratio is 1.32 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Republic Healthcare (HKSE:08357) Overvalued in 2026?
Based on GuruFocus' analysis, Republic Healthcare stock appears to be overvalued.
The current stock price of HK$0.10 is trading 14.4% above its estimated GF Value™ of HK$0.09.
GuruFocus considers Republic Healthcare to be Modestly Overvalued.
Key valuation signals for HKSE:08357:
PB Ratio: 1.32 (16% below median its 10-year median of 1.58)
GF Value™: HK$0.09 vs. price of HK$0.10 (14.4% above fair value)
Industry Position: 33% below the Healthcare Providers & Services median (#183 of 611)
No single metric tells the full story. See the HKSE:08357 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Republic Healthcare Ltd is principally engaged in the clinic business in Singapore and the provision of management advisory services. The company provides healthcare services operating a network of general practice clinics, treatment solutions for common medical conditions with a focus on sexual health and infectious diseases, and operation of a medical aesthetics clinic that focuses on providing treatment solutions for common skin conditions and basic medical aesthetics services. The company is segments are medical services and education services. The Group is engaged in the operation of medical clinics and the provision of management advisory services, pepper trading business, and healthcare-related education business. It generates maximum revenue from Singapore.
30GF Score
Get the complete analysis for HKSE:08357
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08357 has been successfully added to your 
